Liu C, Shen M, Liu Y, Manhas A, et al. CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity. Cell Stem Cell 2024 Nov 5:S1934-5909(24)00369.
PMID: 39515331